Why does cancer recur after seemingly successful treatment?

Many cancers respond initially to therapy but later relapse with resistant variants. Mechanisms include pre-existing resistant clones, induced drug tolerance, dormant 'cancer stem cells' and treatment-driven evolution of the tumour microenvironment.

Understanding which combinations of mechanisms operate in a given tumour, and how to design therapies that pre-empt them, is a major open clinical problem.